Start Date
October 31, 2016
Primary Completion Date
June 30, 2018
Study Completion Date
December 31, 2020
Pembrolizumab
Pembrolizumab 200 mg IV Days 1, 22 and 43
Capecitabine
Capecitabine 825 mg/m2 PO twice a day (daily total 1650 mg/m2) on 5 consecutive days / week M-F given on the radiation days for 28 days
Radiation Therapy
Radiation 50.4 GY in daily fractions of 1.8 Gy over a 6 week interval (excludes weekends)
Collaborators (1)
Hoosier Cancer Research Network
OTHER
Merck Sharp & Dohme LLC
INDUSTRY
Osama Rahma, MD
OTHER